Correction to: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer by Hao Zhang, Yuan Ren, Deyan Pang, Caigang Liu

Get full text

From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies by Zhan Zhang, Yuanzhen Wu, Yanchen Liu, Jingyu Zhang, Yan Zhang, Yunlu Dai, Caigang Liu

Get full text

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer by Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu

Get full text

Oleic Acid Dissolves cGAS–DNA Phase Separation to Inhibit Immune Surveillance by Lina Wang, Qiaoling Liu, Na Wang, Siru Li, Wei Bian, Zhen Sun, Lulu Wang, Li Wang, Caigang Liu, Chengli Song, Quentin Liu, Qingkai Yang

Get full text

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer by Yixiao Zhang, Lisha Sun, Haonan Li, Liping Ai, Qingtian Ma, Xinbo Qiao, Jie Yang, Hao Zhang, Xunyan Ou, Yining Wang, Guanglei Chen, Jinqi Xue, Xudong Zhu, Yu Zhao, Yongliang Yang, Caigang Liu

Get full text

Correction: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer by Yixiao Zhang, Lisha Sun, Haonan Li, Liping Ai, Qingtian Ma, Xinbo Qiao, Jie Yang, Hao Zhang, Xunyan Ou, Yining Wang, Guanglei Chen, Jinqi Xue, Xudong Zhu, Yu Zhao, Yongliang Yang, Caigang Liu

Get full text

Targeting SOST using a small-molecule compound retards breast cancer bone metastasis by Lisha Sun, Yixiao Zhang, Guanglei Chen, Yaoting Ji, Qingtian Ma, Xinbo Qiao, Sijin Wu, Lin Zhou, Jiawen Bu, Xudong Zhu, Xiaoying Zhang, Xiaofan Jiang, Chao Liu, Xinnan Li, Yang Liu, Yongliang Yang, Caigang Liu

Get full text

Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies by Chao Liu, Lisha Sun, Nan Niu, Pengjie Hou, Guanglei Chen, Hao Wang, Zhan Zhang, Xiaofan Jiang, Qianshi Xu, Yafei Zhao, Yimin Wang, Yuan Shi, Mingxin Liu, Yongliang Yang, Wei Qian, Jiandong Wang, Caigang Liu

Get full text

Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pil... by Yu Zhang, Shuo Cao, Nan Niu, Huilian Shan, Jinqi Xue, Guanglei Chen, Yongqing Xu, Jianqiao Yin, Chao Liu, Lisha Sun, Xiaofan Jiang, Meiyue Tang, Qianshi Xu, Mingxuan Jia, Xu Zhang, Zhenyong Zhang, Qingfu Zhang, Jianfei Wang, Ailin Li, Yongliang Yang, Caigang Liu

Get full text

Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial by Nan Niu, Jinqi Xue, Guanglei Chen, Fang Qiu, Qianshi Xu, Xinyu Zheng, Chao Liu, Yafei Zhao, Xi Gu, Yi Zhao, Hong Xu, Hao Zhang, Guijin He, Ke Li, Pengfei Li, Xiaoying Chen, Yong Li, Shuo Wang, Demiao Zhu, Tong Liu, Fei Xing, Yongqing Xu, Ye Han, Meiyue Tang, Mingxin Liu, Gege Jiao, Xiaofan Jiang, Tony Yuen, Zheng Pang, Caigang Liu

Get full text

Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study by Hairong Xu, Yong Zhou, Li Liang, Jingnan Shen, Wangjun Yan, Jin Wang, Jianmin Li, Xiaojing Zhang, Gang Huang, Wenzhi Bi, Zheng Guo, Yanbin Xiao, Jianhua Lin, Weitao Yao, Zhichao Tong, Wenxian Zhou, Guochuan Zhang, Zhaoming Ye, Dong Wang, Jilong Yang, Zhengfu Fan, Caigang Liu, Guofan Qu, Qing Zhang, Feng Wei, Weifeng Liu, Chongqi Tu, Hong Li, Jing Yuan, Xiaohui Niu

Get full text